Lords Mark Industries Unlisted Shares
Lords Mark Industries Ltd — Partners with C-MET to Develop AI-Powered Breast Cancer Detection Device
SCANX
2 min read
Expert Analysis:
Lords Mark Industries Limited has signed a Technology Transfer Agreement (TTA) with the Centre for Materials for Electronic Technology (C-MET), an autonomous research organisation under the Ministry of Electronics and Information Technology (MeitY), to develop and commercialise an AI-powered, radiation-free wearable device for early breast cancer detection.
The proposed device integrates advanced thermal sensors with AI-driven temperature mapping, enabling non-invasive screening capable of detecting early-stage abnormalities without the radiation exposure associated with conventional mammography procedures.
The product is expected to be commercially launched by the end of the current calendar year, with the company aiming to deploy it for mass screening across India and global markets. The initiative targets the expanding breast cancer diagnostics market, projected to reach USD 12.88 billion by 2035.
Key Takeaway:
Lords Mark Industries’ partnership with C-MET positions the company within the emerging AI-driven MedTech diagnostics space, focusing on scalable, radiation-free screening technology that could improve accessibility and early detection of breast cancer globally.
Precize Daily Pulse
The latest news in the world of Unlisted Shares, summarised by our experts.
Company
Our Office
Office No. 1219, The Summit Business Park, Andheri Kurla Road, Andheri East, Mumbai, Maharashtra - 400093
Find us on Googlesupport@precize.in
+91 7738336457
All trademarks and logos or registered trademarks and logos found on this Site or mentioned herein belong to their respective owners and are solely used for informational and educational purposes.
The material presented in this advertisement is for informational purposes only and should not be construed as investment advice or investment availability. It is not a recommendation of, or an offer to sell or solicitation of an offer to buy, any particular unlisted share, security, strategy, or investment product. Investing in the private market and securities involves risks, including the potential loss of money, and past performance does not guarantee future results. Market trends, data interpretations, graph projections are provided for informational and illustrative purposes and may not reflect actual future performance. Nothing on this website should be construed as personalized investment advice or should not be treated as legal, financial, or any other form of advice. Precize is not liable for financial or any other form of loss incurred by the user or any affiliated party based on information provided herein.
Precize is neither a stock exchange nor does it intend to get recognized as a stock exchange under the Securities Contracts Regulation Act, 1956. Precize is not authorized by the capital markets regulator to solicit investments. The securities traded on these platforms are not traded on any regulated exchange.
The website will be updated regularly.
Copyright © 2026 - Precize - All Rights Reserved